INSIDER
Pfizer officially requests FDA emergency use authorization of COVID vaccine in kids 5-11
Read full article: Pfizer officially requests FDA emergency use authorization of COVID vaccine in kids 5-11Pfizer and BioNTech have officially submitted a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization of their COVID-19 vaccine for children aged 5 to 11.
Pfizer submits data to FDA as it seeks to use COVID vaccine in children aged 5-11
Read full article: Pfizer submits data to FDA as it seeks to use COVID vaccine in children aged 5-11Pfizer Inc.and BioNTech announced Tuesday they have submitted data to the U.S. Food and Drug Administration (FDA) from the Phase 2/3 trial of their COVID-19 vaccine in children 5 to 12 years of age.
Pfizer submits data to FDA as it seeks to use COVID vaccine in children aged 5-11
Read full article: Pfizer submits data to FDA as it seeks to use COVID vaccine in children aged 5-11Pfizer plans to request Emergency Use Authorization from the FDA for this age group to receive the vaccine in the coming weeks.
CDC vaccine advisory panel focuses on full FDA approval of Pfizer’s COVID vaccine
Read full article: CDC vaccine advisory panel focuses on full FDA approval of Pfizer’s COVID vaccineThe CDC’s vaccine advisory panel held a public meeting on Monday and discussed the recent full FDA approval of Comirnaty, Pfizer’s COVID vaccine.
Pfizer’s COVID-19 vaccine ‘Comirnaty’ receives full approval from FDA
Read full article: Pfizer’s COVID-19 vaccine ‘Comirnaty’ receives full approval from FDAOn Monday, the U.S. Food and Drug Administration gave full approval to the Pfizer-BioNTech COVID-19 Vaccine, which will now be marketed as Comirnaty.